Evaluation of Inhibitory Action of Novel Non β-Lactam Inhibitor against Klebsiella pneumoniae Carbapenemase (KPC-2)

The use of three classical β-lactamase inhibitors (Clavulanic acid, tazobactam and sulbactam) in combination with β-lactam antibiotics is presently the mainstay of antibiotic therapy against Gram-negative bacterial infections. However these inhibitors are unable to inhibit carbapenemase KPC-2 effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Arbab, Faheem, Mohammad, Danishuddin, Mohd, Khan, Asad U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180753/
https://www.ncbi.nlm.nih.gov/pubmed/25265157
http://dx.doi.org/10.1371/journal.pone.0108246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180753/
https://www.ncbi.nlm.nih.gov/pubmed/25265157
http://dx.doi.org/10.1371/journal.pone.0108246

Ejemplares similares